KAIROS PHARMA, LTD. Earnings Per Share (Basic)
KAIROS PHARMA, LTD. (KAPA) reported Earnings Per Share (Basic) of -$0.06 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- KAIROS PHARMA, LTD. earnings per share, basic for the quarter ending 2026-06-30 was -$0.06.
- KAIROS PHARMA, LTD. earnings per share, basic for the quarter ending 2026-03-31 was -$0.08.
- KAIROS PHARMA, LTD. earnings per share, basic for the quarter ending 2025-12-31 was -$0.07.
- KAIROS PHARMA, LTD. earnings per share, basic for the quarter ending 2025-09-30 was -$0.07.
- KAIROS PHARMA, LTD. earnings per share, basic for fiscal 2025 was -$0.30.
- KAIROS PHARMA, LTD. earnings per share, basic for fiscal 2024 was -$0.23.
- KAIROS PHARMA, LTD. earnings per share, basic for fiscal 2023 was -$0.17.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.06 10-Q · filed 2026-08-12 | -$0.14 10-Q · filed 2026-08-12 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2026-03-31 | -$0.08 10-Q · filed 2026-05-13 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.30 10-K · filed 2026-03-31 |
| 2025-09-30 | -$0.07 10-Q · filed 2025-11-14 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.23 10-Q · filed 2025-11-14 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-06-30 | -$0.08 10-Q · filed 2026-08-12 | -$0.16 10-Q · filed 2026-08-12 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-03-31 | -$0.08 10-Q · filed 2026-05-13 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-05-13 |
| 2024-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.23 10-K · filed 2026-03-31 |
| 2024-09-30 | -$0.10 10-Q · filed 2025-11-14 | -$0.12 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$0.15 10-Q · filed 2025-11-14 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-11-14 |
| 2024-06-30 | -$0.02 10-Q · filed 2025-08-12 | -$0.05 10-Q · filed 2025-08-12 | -$0.16 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$0.19 derived: net income ÷ weighted average shares · filed 2025-08-12 |
| 2024-03-31 | -$0.03 10-Q · filed 2025-05-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$0.17 derived: net income ÷ weighted average shares · filed 2025-05-14 | |
| 2023-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2025-04-15 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-04-15 | -$0.17 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$0.03 10-Q · filed 2024-11-14 | -$0.07 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |